Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|January 17, 2019
Endovascular management of arterio-ureteral fistula in a patient with a challenging hematuriaQinzong Gao, Jing Zhao, Ning Yang, et al.
Journal of Cancer Research and Therapeutics|February 24, 2017
Safety and feasibility within 24 h of discharge in patents with inoperable malignant lung nodules after percutaneous microwave ablationBin Li, Zhiwei Wang, Kang Zhou, et al.
Scientific Reports|April 30, 2021
Reduction of microwave ablation needle related metallic artifacts using virtual monoenergetic images from dual-layer detector spectral CT in a rabbit model with VX2 tumorGuorong Wang, Qinzong Gao, Zhiwei Wang, et al.
Biomacromolecules|March 1, 2024
Construction of an Injectable Composite Double-Network Hydrogel as a Liquid Embolic AgentShili Ai, Qinzong Gao, Gele Cheng, et al.
Translational Oncology|May 31, 2023
A Novel Nomogram for Predicting the Overall Survival in Patients with Unresectable HCC after TACE plus Hepatic Arterial Infusion ChemotherapyBaojiang Liu, Song Gao, Jianhai Guo, et al.
Journal of Hepatocellular Carcinoma|March 11, 2024
Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular CarcinomaBaojiang Liu, Song Gao, Jianhai Guo, et al.
International Immunopharmacology|March 2, 2024
High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapyBaojiang Liu, Song Gao, Jianhai Guo, et al.
Therapeutic Advances in Medical Oncology|June 8, 2026
Efficacy and safety of drug-eluting bead transarterial chemoembolization combined with hepatic arterial infusion chemotherapy in unresectable gastric cancer with liver metastasisBaojiang Liu, Di Wu, Song Gao, et al.
Journal of Cancer Research and Therapeutics|June 4, 2026
Combining partial splenic embolization with hepatic artery infusion chemotherapy in the management of chemotherapy-induced hypersplenism in patients with colorectal cancer liver metastasesBaojiang Liu, Song Gao, Hui Zheng, et al.
Pageof 1